Analyzing and Modeling the Spread of SARS-CoV-2 Omicron Lineages BA.1 and BA.2, France, September 2021–February 2022

We analyzed 324,734 SARS-CoV-2 variant screening tests from France enriched with 16,973 whole-genome sequences sampled during September 1, 2021–February 28, 2022. Results showed the estimated growth advantage of the Omicron variant over the Delta variant to be 105% (95% CI 96%–114%) and that of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sofonea, Mircea T., Roquebert, Bénédicte, Foulongne, Vincent, Morquin, David, Verdurme, Laura, Trombert-Paolantoni, Sabine, Roussel, Mathilde, Bonetti, Jean-Christophe, Zerah, Judith, Haim-Boukobza, Stéphanie, Alizon, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239895/
https://www.ncbi.nlm.nih.gov/pubmed/35642476
http://dx.doi.org/10.3201/eid2807.220033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239895/
https://www.ncbi.nlm.nih.gov/pubmed/35642476
http://dx.doi.org/10.3201/eid2807.220033

Ejemplares similares